// App-Quantinova.ai

93 : Development and Validation of the Collagen Neo‐Epitope Biomarker Pro‐C3 “FIB‐C3 Score” for Detection and Staging of Advanced NonAlcoholic Fatty Liver Disease in a Large International Multi‐Centre Patient Cohort

Researchers

Presenter

  • Marie P. Boyle

Principal Investigators

  • Dina G. Tiniakos

  • Stuart McPherson

  • Vlad Ratziu

  • Pierre Bedossa

  • Timothy Hardy

  • Jrn M. Schattenberg

  • Claudia P. Oliveira

  • Elisabetta Bugianesi

  • Salvatore Petta

  • Mette J. Nielsen

  • Morten A. Karsdal

  • Diana J. Leeming

  • Stuart Kendrick

Medical Centers

  • Institute of Cellular Medicine, Newcastle University, Newcastle Upon Tyne, United Kingdom

  • IFCT, Paris, France

  • HEGP, Paris, France

  • University of Mainz, Mainz, Germany

  • University of Sao Paulo, Sao Paulo, Brazil

  • University of Turin, Turin, Italy

  • University of Palermo, Palermo, Italy

  • GlaxoSmithKline Research & Development Ltd, Stevenage, United Kingdom

  • Nordic Bioscience, Herlev, Denmark

Locations

  • United Kingdom

  • France

  • Germany

  • Brazil

  • Italy

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Nonalcoholic fatty liver disease

  • Cirrhosis

  • Nonalcoholic steatohepatitis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved